What is Legionella? What are monitoring & - - PDF document

what is legionella what are monitoring amp control
SMART_READER_LITE
LIVE PREVIEW

What is Legionella? What are monitoring & - - PDF document

What is Legionella? What are monitoring & control recommendations? What are you required to monitor/control? What are you required to monitor/control? What are the risks? How can


slide-1
SLIDE 1
slide-2
SLIDE 2
  • What is Legionella?

What are monitoring & control recommendations? What are you required to monitor/control? What are you required to monitor/control? What are the risks? How can Watertech help?

slide-3
SLIDE 3
slide-4
SLIDE 4
  • Gram negative, waterborne pathogen.

Family encompasses more than 40 different organisms, only a few of which endanger health. Contracted by inhalation of aerosols or aspiration of water. Immunocompromised and respiratory compromised individuals are at greatest risk. individuals are at greatest risk. An estimated 8,000 - 18,000 cases of legionellosis occur each year in the U.S; 23% are nosocomial. Most LD cases are sporadic; 10% - 20% can be linked to outbreaks. Death occurs in 5% - 15% of LD cases; a substantially higher proportion of fatal cases occur during nosocomial outbreaks.

slide-5
SLIDE 5

! !

slide-6
SLIDE 6

"#$%%% "#$%%%

slide-7
SLIDE 7

&' &'( ()#*#+ )#*#+

,-.- /* $/ 0-+

7

0-+ &- " + 1+2 &+ 3

  • $

Klenzoid Inc

slide-8
SLIDE 8

4-)# 4-)#

,-.- /* 0-+

8

$/ 0-+ &- " + 1+2 &+ 3

slide-9
SLIDE 9

5-$ 5-$ 3#-6& 3#-6&

  • 73/85-.

9/)-* / /++ ) :.-;0+-4-

  • &/#-

:.-;0+-4-

  • &/#-

85$- .&--: ,<+-4+75-- 4+-&/

slide-10
SLIDE 10

7.-.5*:'6&=+ 7.-.5*:'6&=+ $ +/ $ +/

#-*-$#-

  • .1#$#2

:.-/-

1:2

# "+ /- & *-

,*--- #:- 1&,:2

#> # "+

1#"2

?#//*-

  • *

7 +&*

/- 17&2

#>

$-/13+-2

8@A$&$-/

*

0- -&/

slide-11
SLIDE 11

?#76&// ?#76&//

&-:#>> //-+/>! "*:#>> // -35 // -35

  • B53/+

///--/9 C!9

slide-12
SLIDE 12

6&// 6&//

3

  • !"#

!"# $ !! %! %$"& &+- ( &:

slide-13
SLIDE 13

=+*--.*-$ =+*--.*-$ *-6>&> - *-6>&> -

slide-14
SLIDE 14

#B,1- .2 #B,1- .2

  • .*,)
  • .*,)

#+ ( <+- Culture hot water tanks & distal sites. Legionella found? Prior cases of nosocomial legionellosis observed?

YES YES NO NO

  • -.*

<+--$ Colonization of distal sites > 30% Prospective surveillance for nosocomial LD detected? Consider Disinfection Continue environmental surveillance

NO YES NO YES

slide-15
SLIDE 15

0$- .D&/,)/ 0$- .D&/,)/ *- *- -

slide-16
SLIDE 16

# "+1#"2 # "+1#"2 &-#"&$ &-#"&$( (E E

&-3-. +*-)

  • *<+* *5-
  • /-

$ * 5+3+ $ * 5+3+

  • -*- >
slide-17
SLIDE 17

#++-F% #++-F%

#++-,+ @+D

& A--+- "*-/ 16-*-> +/--+2 0-*** ** **- 0-*** ** **-

slide-18
SLIDE 18

/- & *-,*--- /- & *-,*--- #:-1&,:2 #:-1&,:2 =+G17=+2 DHH555>->- DHH555>3/-- > / F- //D F- //D

/ 63 -/--/ #+<+*5--/

slide-19
SLIDE 19

"GII85&,: "GII85&,:

  • &-9,-8

&-9,-8

slide-20
SLIDE 20

&+*&,:&# &+*&,:&#( (JJ JJ

  • " +3 ,.5 7 > 8.>EGII
  • <+-/--.53

//-.>

  • $&-*-/ +D
  • $&-*-/ +D
  • 3-&/
  • #5-:.-.#-
  • &
  • $ -.+7--+-
  • $- "- :.-.#--

+/*---

slide-21
SLIDE 21

&,: &,:&# &#( (JJ JJ

&-#.-D

$ 7-

  • -/15- 32

&-6H&+$5- +- $*

slide-22
SLIDE 22

&,:=+G &,:=+G 3 3&8$,$ &8$,$%

Elements of Standard 188 (SPC-188):

Requirement for Hazard Analysis (HACCP) Documentation of water systems, operation and maintenance as it relates to reducing/controlling Legionella Legionella Verification that the controls are “in range” Validation that the hazard (Legionella) is under control = culturing is the only way to accurately validate effectiveness of the program

slide-23
SLIDE 23
  • &/

/

/H #//+

  • &*
  • &*

&+-. 102

slide-24
SLIDE 24
  • 5$-/
  • 5$-/
slide-25
SLIDE 25
slide-26
SLIDE 26
  • A#-,)
  • A#-,)

Risks OF NOT monitoring & controlling

#-+% 5-

/*

  • +-)
  • +-)
  • :.
  • / **

3/*

  • B
slide-27
SLIDE 27
  • A#-,)
  • A#-,)
slide-28
SLIDE 28
  • A#-,)
  • A#-,)

,) /-A -

@+/*+.-3/%% ./////

B-( # /H # /H # 5-,<+-/

&/ $ +// -*-//

:.-/-H&+-. :<+/

+/ & -$*

slide-29
SLIDE 29
  • A#-,)
  • A#-,)
slide-30
SLIDE 30
  • .$$
  • .$$

:** .

  • ./-*

5-/ #++-+ 3 5- 1'B-K'B-2 "*. B

"** .

5-/-+- LI) $-/. 3 */ * "*. B 1M.2*5-/ 5-/ *

  • -

+/ *H -- . H/ * ,/.*-- #/ -/* 5- 3 */ *

slide-31
SLIDE 31

5#- 5#-

,+- 1555>.-> /2 5B-#- #- 1##2 , -F

&-. &-.

012 +&-. 34-#--/ 31555>5- +> /2 & -$* 1$"7N-

  • -/2
slide-32
SLIDE 32

# + # +

:.--*-/> 1-$2-.3% 5- /.. 3+* //

  • .5 +
  • .5 +

3* 53 -+/>! #++- - -*.- >

slide-33
SLIDE 33

& ) & )

  • Dr. Janet Stout – Special Pathogens Lab
  • Mr. Joseph Hannigan – Klenzoid Inc.